Substitutions of PrP N-terminal histidine residues modulate scrapie disease pathogenesis and incubation time in transgenic mice

Autor: Hans A. Kretzschmar, Marko Maringer, Nathalie Daude, Alexander Hepp, David Westaway, Gerda Mitteregger-Kretzschmar, Janina Mielke, Sabina Eigenbrod, Armin Giese, Petra Frick, Vignesh Sakthivelu, Jörg Tatzelt, Uwe Bertsch, Otto Windl, Niklas Piening, Johannes Levin
Rok vydání: 2017
Předmět:
0301 basic medicine
Central Nervous System
animal diseases
lcsh:Medicine
Scrapie
Biochemistry
Nervous System
chemistry [Prion Proteins]
law.invention
Animal Diseases
Prion Diseases
Mice
law
chemistry [Histidine]
Zoonoses
Medicine and Health Sciences
Amino Acids
lcsh:Science
Brain Diseases
Multidisciplinary
Chemistry
Organic Compounds
Animal Models
Proteases
Phenotype
Enzymes
Animal Prion Diseases
Infectious Diseases
Experimental Organism Systems
Neurology
Physical Sciences
Recombinant DNA
Basic Amino Acids
Anatomy
Research Article
pathology [Scrapie]
Gene isoform
Genetically modified mouse
Transgene
Mice
Transgenic

Mouse Models
Research and Analysis Methods
Prion Proteins
03 medical and health sciences
Model Organisms
In vivo
Animals
Histidine
ddc:610
lcsh:R
Organic Chemistry
Chemical Compounds
Biology and Life Sciences
Proteins
Molecular biology
nervous system diseases
030104 developmental biology
Enzymology
lcsh:Q
Zoology
Zdroj: PLoS ONE
PLoS ONE, Vol 12, Iss 12, p e0188989 (2017)
PLOS ONE 12(12), e0188989 (2017). doi:10.1371/journal.pone.0188989
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0188989
Popis: Prion diseases have been linked to impaired copper homeostasis and copper induced-oxidative damage to the brain. Divalent metal ions, such as Cu2+ and Zn2+, bind to cellular prion protein (PrPC) at octapeptide repeat (OR) and non-OR sites within the N-terminal half of the protein but information on the impact of such binding on conversion to the misfolded isoform often derives from studies using either OR and non-OR peptides or bacterially-expressed recombinant PrP. Here we created new transgenic mouse lines expressing PrP with disrupted copper binding sites within all four histidine-containing OR's (sites 1-4, H60G, H68G, H76G, H84G, 'TetraH>G' allele) or at site 5 (composed of residues His-95 and His-110; 'H95G' allele) and monitored the formation of misfolded PrP in vivo. Novel transgenic mice expressing PrP(TetraH>G) at levels comparable to wild-type (wt) controls were susceptible to mouse-adapted scrapie strain RML but showed significantly prolonged incubation times. In contrast, amino acid replacement at residue 95 accelerated disease progression in corresponding PrP(H95G) mice. Neuropathological lesions in terminally ill transgenic mice were similar to scrapie-infected wt controls, but less severe. The pattern of PrPSc deposition, however, was not synaptic as seen in wt animals, but instead dense globular plaque-like accumulations of PrPSc in TgPrP(TetraH>G) mice and diffuse PrPSc deposition in (TgPrP(H95G) mice), were observed throughout all brain sections. We conclude that OR and site 5 histidine substitutions have divergent phenotypic impacts and that cis interactions between the OR region and the site 5 region modulate pathogenic outcomes by affecting the PrP globular domain.
Databáze: OpenAIRE